chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Primary myelofibrosis, Respiratory disorder, SARS-CoV-2 test positive, Sleep deficit, Superinfection
Clinical narrative: Patien is an 85 y.o. female who presented to the local Hospital ED from an independent living facility  on 2/4/2023 with increasing shortness of breath and worsening cough following recent SARS-CoV-2/COVID-19 diagnosis.  Patient was found to be in acute hypoxic respiratory failure and required heated high flow O2.  Pulmonology/critical care evaluated and assisted with management.  Despite aggressive medical management, patient's hypoxia and shortness of breath persisted while on heated high flow.  On 2/10 morning, patient discussed with family that she did not want to continue aggressive treatment.  At that time, patient was sound of body and mind.  Family agreed to withdraw care and proceed with comfort care.  Patient expired 2/10/2023.  Family was at bedside.  Acute hypoxemic respiratory failure -Secondary to COVID-19 pneumonia and superimposed bacterial pneumonia with pre-existing interstitial lung disease -Despite aggressive treatment while on heated high flow oxygen, patient did not improve -Family agreed to comfort care.   COVID-19 Presumed bacterial pneumonia -Presented with cough and shortness of breath - Symptom onset: 1/27/2023 - Positive COVID-19: 1/28/23 at a HCF facility - Vaccination status: Vaccinated + boosters - CTPE on admission showed ground glass mid-upper lung changes, and dependent lower lobe consolidation.  No PE. - Oxygen status: Heated high flow -Status: Not improving - Decadron: Patient was treated with Decadron during hospitalization - Remdesivir: No.  Completed antiviral therapy with nirmatrelvir/ritonavir -Tocilizumab: No.  Patient did not qualify.  Acute encephalopathy -Secondary to sleep deprivation, sundowning, and respiratory issues   Hyponatremia -Most likely related to decreased oral in setting of acute illness +/- mild SIADH in setting of active pulmonary process  -Resolved    Elevated troponin -Likely related to hypoxemia and demand ischemia.   Hypokalemia -Resolved   Primary myelofibrosis -Follows with Dr. at a HCF, treated with Jakafi, with reduced dosing (50% reduction) for recent nirmatrelvir/ritonavir use -Jakafi was on hold during hospitalization since patient was on steroids  Interstitial lung disease Suspected, initial diagnosis in fall of 2022 after hospitalization at RMH, possibly drug-induced (macrobid). -Follows with pulmonology (Dr.).   Essential hypertension   Pulmonary hypertension With echo in fall of 2022 revealing RVSP of 55 mg Hg.  Possibly related to chronic lung disease
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Therapy cessation, Therapy change, Troponin increased
Clinical narrative: Patien is an 85 y.o. female who presented to the local Hospital ED from an independent living facility  on 2/4/2023 with increasing shortness of breath and worsening cough following recent SARS-CoV-2/COVID-19 diagnosis.  Patient was found to be in acute hypoxic respiratory failure and required heated high flow O2.  Pulmonology/critical care evaluated and assisted with management.  Despite aggressive medical management, patient's hypoxia and shortness of breath persisted while on heated high flow.  On 2/10 morning, patient discussed with family that she did not want to continue aggressive treatment.  At that time, patient was sound of body and mind.  Family agreed to withdraw care and proceed with comfort care.  Patient expired 2/10/2023.  Family was at bedside.  Acute hypoxemic respiratory failure -Secondary to COVID-19 pneumonia and superimposed bacterial pneumonia with pre-existing interstitial lung disease -Despite aggressive treatment while on heated high flow oxygen, patient did not improve -Family agreed to comfort care.   COVID-19 Presumed bacterial pneumonia -Presented with cough and shortness of breath - Symptom onset: 1/27/2023 - Positive COVID-19: 1/28/23 at a HCF facility - Vaccination status: Vaccinated + boosters - CTPE on admission showed ground glass mid-upper lung changes, and dependent lower lobe consolidation.  No PE. - Oxygen status: Heated high flow -Status: Not improving - Decadron: Patient was treated with Decadron during hospitalization - Remdesivir: No.  Completed antiviral therapy with nirmatrelvir/ritonavir -Tocilizumab: No.  Patient did not qualify.  Acute encephalopathy -Secondary to sleep deprivation, sundowning, and respiratory issues   Hyponatremia -Most likely related to decreased oral in setting of acute illness +/- mild SIADH in setting of active pulmonary process  -Resolved    Elevated troponin -Likely related to hypoxemia and demand ischemia.   Hypokalemia -Resolved   Primary myelofibrosis -Follows with Dr. at a HCF, treated with Jakafi, with reduced dosing (50% reduction) for recent nirmatrelvir/ritonavir use -Jakafi was on hold during hospitalization since patient was on steroids  Interstitial lung disease Suspected, initial diagnosis in fall of 2022 after hospitalization at RMH, possibly drug-induced (macrobid). -Follows with pulmonology (Dr.).   Essential hypertension   Pulmonary hypertension With echo in fall of 2022 revealing RVSP of 55 mg Hg.  Possibly related to chronic lung disease
Age: 36.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Mobility decreased
Clinical narrative: C/O shoulder pain day after vaccination and reports difficulty lifting weights at the gym on 3/1/23.  No treatment. Referred to his primary care.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anaemia, Atrial fibrillation, Blood creatinine increased, Blood glucose
Clinical narrative: History of Present Illness:  Patient is a 80 y.o. female presenting from home with c/o SOB.   Per emergency room report, patient presented to emergency room for evaluation of shortness of breath.  Patient has been feeling short of breath over the past few weeks and this is worsened over the past few days.  Patient reported nonproductive cough.  Patient denies any known fever.  Patient recently had COVID in October.  Patient denies any chest pain or increased leg swelling.   #1 acute on chr systolic CHF secondary to cardiomyopathy with ejection fraction of 37% We had pt on lasix but weaned it down due to climbing creat 2/4 0300: developed SOB. CXR showed pulm edema. Has now received 2 doses of IV lasix.  2/5: creat stable  2.  Anemia and positive Hemoccults  2/3: C-scope: severe diverticular disease 2/4: EGD: mild gastritis. Biopsy taken  3.  Acute hypoxic respiratory failure with hypercapnia secondary to COVID   patient is done with the Decadron and her isolation is off and her COVID test was positive in January 19 and was positive before in October of last year not sure if this is a new infection 2/5: room air oO2 sat runs 86-88. On 2 L NC O2 sat > 90 % 2/5: before DC today home oxygen will be set up 2/5: face to face done on 2/1 by Dr. for home O2  4.  Hypertension Quite stable  5 diabetes Hosp gluc goal is < 180: goal being met Will cont with current tx plan  6.  New onset paroxysmal A-fib  Due to pt's age and mental state, cardiology deferred Full dose ASA for anticoag Will cont Amiod and Toprol  8.  Baseline dementia  9.  History of depression and anxiety and blindness   10. herpes zoster (L) upper buttock Valtrex for 7 days    Patient is a DNR CCA We have talked several times about sending her to snf but husband refused
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure acute, Cardiac failure congestive, Cardiomyopathy, Chest X-ray abnormal
Clinical narrative: History of Present Illness:  Patient is a 80 y.o. female presenting from home with c/o SOB.   Per emergency room report, patient presented to emergency room for evaluation of shortness of breath.  Patient has been feeling short of breath over the past few weeks and this is worsened over the past few days.  Patient reported nonproductive cough.  Patient denies any known fever.  Patient recently had COVID in October.  Patient denies any chest pain or increased leg swelling.   #1 acute on chr systolic CHF secondary to cardiomyopathy with ejection fraction of 37% We had pt on lasix but weaned it down due to climbing creat 2/4 0300: developed SOB. CXR showed pulm edema. Has now received 2 doses of IV lasix.  2/5: creat stable  2.  Anemia and positive Hemoccults  2/3: C-scope: severe diverticular disease 2/4: EGD: mild gastritis. Biopsy taken  3.  Acute hypoxic respiratory failure with hypercapnia secondary to COVID   patient is done with the Decadron and her isolation is off and her COVID test was positive in January 19 and was positive before in October of last year not sure if this is a new infection 2/5: room air oO2 sat runs 86-88. On 2 L NC O2 sat > 90 % 2/5: before DC today home oxygen will be set up 2/5: face to face done on 2/1 by Dr. for home O2  4.  Hypertension Quite stable  5 diabetes Hosp gluc goal is < 180: goal being met Will cont with current tx plan  6.  New onset paroxysmal A-fib  Due to pt's age and mental state, cardiology deferred Full dose ASA for anticoag Will cont Amiod and Toprol  8.  Baseline dementia  9.  History of depression and anxiety and blindness   10. herpes zoster (L) upper buttock Valtrex for 7 days    Patient is a DNR CCA We have talked several times about sending her to snf but husband refused
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Colonoscopy abnormal, Cough, Diverticulum, Dyspnoea, Ejection fraction decreased
Clinical narrative: History of Present Illness:  Patient is a 80 y.o. female presenting from home with c/o SOB.   Per emergency room report, patient presented to emergency room for evaluation of shortness of breath.  Patient has been feeling short of breath over the past few weeks and this is worsened over the past few days.  Patient reported nonproductive cough.  Patient denies any known fever.  Patient recently had COVID in October.  Patient denies any chest pain or increased leg swelling.   #1 acute on chr systolic CHF secondary to cardiomyopathy with ejection fraction of 37% We had pt on lasix but weaned it down due to climbing creat 2/4 0300: developed SOB. CXR showed pulm edema. Has now received 2 doses of IV lasix.  2/5: creat stable  2.  Anemia and positive Hemoccults  2/3: C-scope: severe diverticular disease 2/4: EGD: mild gastritis. Biopsy taken  3.  Acute hypoxic respiratory failure with hypercapnia secondary to COVID   patient is done with the Decadron and her isolation is off and her COVID test was positive in January 19 and was positive before in October of last year not sure if this is a new infection 2/5: room air oO2 sat runs 86-88. On 2 L NC O2 sat > 90 % 2/5: before DC today home oxygen will be set up 2/5: face to face done on 2/1 by Dr. for home O2  4.  Hypertension Quite stable  5 diabetes Hosp gluc goal is < 180: goal being met Will cont with current tx plan  6.  New onset paroxysmal A-fib  Due to pt's age and mental state, cardiology deferred Full dose ASA for anticoag Will cont Amiod and Toprol  8.  Baseline dementia  9.  History of depression and anxiety and blindness   10. herpes zoster (L) upper buttock Valtrex for 7 days    Patient is a DNR CCA We have talked several times about sending her to snf but husband refused
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Gastritis, Gastrointestinal tract biopsy, Herpes zoster, Hypertension, Left ventricular failure
Clinical narrative: History of Present Illness:  Patient is a 80 y.o. female presenting from home with c/o SOB.   Per emergency room report, patient presented to emergency room for evaluation of shortness of breath.  Patient has been feeling short of breath over the past few weeks and this is worsened over the past few days.  Patient reported nonproductive cough.  Patient denies any known fever.  Patient recently had COVID in October.  Patient denies any chest pain or increased leg swelling.   #1 acute on chr systolic CHF secondary to cardiomyopathy with ejection fraction of 37% We had pt on lasix but weaned it down due to climbing creat 2/4 0300: developed SOB. CXR showed pulm edema. Has now received 2 doses of IV lasix.  2/5: creat stable  2.  Anemia and positive Hemoccults  2/3: C-scope: severe diverticular disease 2/4: EGD: mild gastritis. Biopsy taken  3.  Acute hypoxic respiratory failure with hypercapnia secondary to COVID   patient is done with the Decadron and her isolation is off and her COVID test was positive in January 19 and was positive before in October of last year not sure if this is a new infection 2/5: room air oO2 sat runs 86-88. On 2 L NC O2 sat > 90 % 2/5: before DC today home oxygen will be set up 2/5: face to face done on 2/1 by Dr. for home O2  4.  Hypertension Quite stable  5 diabetes Hosp gluc goal is < 180: goal being met Will cont with current tx plan  6.  New onset paroxysmal A-fib  Due to pt's age and mental state, cardiology deferred Full dose ASA for anticoag Will cont Amiod and Toprol  8.  Baseline dementia  9.  History of depression and anxiety and blindness   10. herpes zoster (L) upper buttock Valtrex for 7 days    Patient is a DNR CCA We have talked several times about sending her to snf but husband refused
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Occult blood positive, Oesophagogastroduodenoscopy abnormal, Pulmonary oedema, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: History of Present Illness:  Patient is a 80 y.o. female presenting from home with c/o SOB.   Per emergency room report, patient presented to emergency room for evaluation of shortness of breath.  Patient has been feeling short of breath over the past few weeks and this is worsened over the past few days.  Patient reported nonproductive cough.  Patient denies any known fever.  Patient recently had COVID in October.  Patient denies any chest pain or increased leg swelling.   #1 acute on chr systolic CHF secondary to cardiomyopathy with ejection fraction of 37% We had pt on lasix but weaned it down due to climbing creat 2/4 0300: developed SOB. CXR showed pulm edema. Has now received 2 doses of IV lasix.  2/5: creat stable  2.  Anemia and positive Hemoccults  2/3: C-scope: severe diverticular disease 2/4: EGD: mild gastritis. Biopsy taken  3.  Acute hypoxic respiratory failure with hypercapnia secondary to COVID   patient is done with the Decadron and her isolation is off and her COVID test was positive in January 19 and was positive before in October of last year not sure if this is a new infection 2/5: room air oO2 sat runs 86-88. On 2 L NC O2 sat > 90 % 2/5: before DC today home oxygen will be set up 2/5: face to face done on 2/1 by Dr. for home O2  4.  Hypertension Quite stable  5 diabetes Hosp gluc goal is < 180: goal being met Will cont with current tx plan  6.  New onset paroxysmal A-fib  Due to pt's age and mental state, cardiology deferred Full dose ASA for anticoag Will cont Amiod and Toprol  8.  Baseline dementia  9.  History of depression and anxiety and blindness   10. herpes zoster (L) upper buttock Valtrex for 7 days    Patient is a DNR CCA We have talked several times about sending her to snf but husband refused
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Headache, Intraocular pressure increased, Vitreous floaters
Clinical narrative: I was noticing I developed an eye floater which was very large and noticeable. I also had ocular pressure like a headache. The floater was in the right eye. I went to the eye doctor, and she completed a test to check the eye pressure. The results show that the pressure was abnormally high. She did not have any specific cause or diagnosis. She gave me some drops to relieve the pressure. The symptoms are still kind of the same. I am also taking over the counter decongestant as it was also thought that it could be sinus pressure. I have a follow up appointment coming up.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Confusional state, Cough
Clinical narrative: Patient brought to the ED by EMS on 12/3/22 for generalized weakness, persistent cough, and confusion. En route to the ED, patient's oxygen sats was 88% so was placed on oxygen. She tested positive for COVID by PCR in the ED, and was admitted on 12/3/22 for hypoxic respiratory failure due to COVID-19 pneumonia, dysphagia and possible aspiration pneumonia, among other problems. She initially required O2 and was on decadron, however was able to be weaned off oxygen. Her COVID pneumonia resolved during her admission. Patient has received the COVID primary vaccine series and two boosters.  Of note, during admission patient continued to have persistent encephalopathy, dysphagia, and suspected LLL aspiration pneumonia. Ultimately she was transitioned to comfort focused care on 12/27, and expired in the hospital on 12/30/22. Cause of death documented in the chart is respiratory failure secondary to aspiration pneumonia.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Death, Dysphagia, Encephalopathy, Pneumonia aspiration, Respiratory failure
Clinical narrative: Patient brought to the ED by EMS on 12/3/22 for generalized weakness, persistent cough, and confusion. En route to the ED, patient's oxygen sats was 88% so was placed on oxygen. She tested positive for COVID by PCR in the ED, and was admitted on 12/3/22 for hypoxic respiratory failure due to COVID-19 pneumonia, dysphagia and possible aspiration pneumonia, among other problems. She initially required O2 and was on decadron, however was able to be weaned off oxygen. Her COVID pneumonia resolved during her admission. Patient has received the COVID primary vaccine series and two boosters.  Of note, during admission patient continued to have persistent encephalopathy, dysphagia, and suspected LLL aspiration pneumonia. Ultimately she was transitioned to comfort focused care on 12/27, and expired in the hospital on 12/30/22. Cause of death documented in the chart is respiratory failure secondary to aspiration pneumonia.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient brought to the ED by EMS on 12/3/22 for generalized weakness, persistent cough, and confusion. En route to the ED, patient's oxygen sats was 88% so was placed on oxygen. She tested positive for COVID by PCR in the ED, and was admitted on 12/3/22 for hypoxic respiratory failure due to COVID-19 pneumonia, dysphagia and possible aspiration pneumonia, among other problems. She initially required O2 and was on decadron, however was able to be weaned off oxygen. Her COVID pneumonia resolved during her admission. Patient has received the COVID primary vaccine series and two boosters.  Of note, during admission patient continued to have persistent encephalopathy, dysphagia, and suspected LLL aspiration pneumonia. Ultimately she was transitioned to comfort focused care on 12/27, and expired in the hospital on 12/30/22. Cause of death documented in the chart is respiratory failure secondary to aspiration pneumonia.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Asthenia, Blood creatinine increased, Blood culture positive
Clinical narrative: Patient is a 68 y.o. male patient of local MD with a history of SOB   Discharge Diagnoses:   Assessment/Plan: Patient is a 68 y.o. male who presented to local Hospital 2/8/2023 with shortness of breath, weakness.   1. SIRS s/t PNA a. CT CAP without contrast: BLL consolidation/opacities c/w pneumonia 2. Lactic Acidosis a. 5.4 on admission, 3.0 (2/9) 3. Acute Hypoxemic Respiratory Failure (RESOLVED) 4. Bacterial Pneumonia BLL (CAP POA) a. Vanco stopped due to Cr level b. Rocephin continued Day #2.   5. Positive Blood Cx - S. Pneumoniae a. Blood PCR positive for S. Pneumoniae.  b. Was on Vanco and Zosyn, transitioned to IV Rocephin Day #2. Vanco stopped due to Cr.  6. COVID-19 Infection a. Date of onset of symptoms:  2/2/23 b. Symptoms present on admission: Hypoxemia c. Date of covid positive test:  2/8/23 d. Vaccination status:  x2 vaccines e. Imaging:   CT CAP with BLL pneumonia f. Oxygen requirements on admission:   3LPM g. Current oxygen requirements: RA h. Medical therapy: Decadron i. Consultants following:  Cardio, Nephrology consulted j. Anticipated special isolation end date 2/18/2023 k. CRP and Sed rate monitored--elevated 2/9 7. AKI on CKD a. Nephrology states okay to discharge. Recommends Lasix 40 mg daily  b. Likely multifactorial including COVID-19 creatinine has improved to 2.4 8. Hyperglycemia, Type II DM a. Elevation noted due to steroid use.  b. Will increase NPH dosing as current BG running 250-300s. 9. HF with mild reduction in EF, chronic a. Reviewed echo from 5/2022: EF 43%, grade II diastolic dysfunction, moderate LVH, moderate enlargement of the LA chamber, mild MV regurg, mild TV regurg, pulm HTN RVSP 43mmHg b. Continue antiarrhythmics and Eliquis per home regimen 10. Other Chronic Conditions include: CAD, HTN, H/O MI, H/O stent to LAD, H/O AFIB s/p ablation x1.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid increased, C-reactive protein increased, COVID-19, Cardiac failure, Chronic kidney disease
Clinical narrative: Patient is a 68 y.o. male patient of local MD with a history of SOB   Discharge Diagnoses:   Assessment/Plan: Patient is a 68 y.o. male who presented to local Hospital 2/8/2023 with shortness of breath, weakness.   1. SIRS s/t PNA a. CT CAP without contrast: BLL consolidation/opacities c/w pneumonia 2. Lactic Acidosis a. 5.4 on admission, 3.0 (2/9) 3. Acute Hypoxemic Respiratory Failure (RESOLVED) 4. Bacterial Pneumonia BLL (CAP POA) a. Vanco stopped due to Cr level b. Rocephin continued Day #2.   5. Positive Blood Cx - S. Pneumoniae a. Blood PCR positive for S. Pneumoniae.  b. Was on Vanco and Zosyn, transitioned to IV Rocephin Day #2. Vanco stopped due to Cr.  6. COVID-19 Infection a. Date of onset of symptoms:  2/2/23 b. Symptoms present on admission: Hypoxemia c. Date of covid positive test:  2/8/23 d. Vaccination status:  x2 vaccines e. Imaging:   CT CAP with BLL pneumonia f. Oxygen requirements on admission:   3LPM g. Current oxygen requirements: RA h. Medical therapy: Decadron i. Consultants following:  Cardio, Nephrology consulted j. Anticipated special isolation end date 2/18/2023 k. CRP and Sed rate monitored--elevated 2/9 7. AKI on CKD a. Nephrology states okay to discharge. Recommends Lasix 40 mg daily  b. Likely multifactorial including COVID-19 creatinine has improved to 2.4 8. Hyperglycemia, Type II DM a. Elevation noted due to steroid use.  b. Will increase NPH dosing as current BG running 250-300s. 9. HF with mild reduction in EF, chronic a. Reviewed echo from 5/2022: EF 43%, grade II diastolic dysfunction, moderate LVH, moderate enlargement of the LA chamber, mild MV regurg, mild TV regurg, pulm HTN RVSP 43mmHg b. Continue antiarrhythmics and Eliquis per home regimen 10. Other Chronic Conditions include: CAD, HTN, H/O MI, H/O stent to LAD, H/O AFIB s/p ablation x1.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Dyspnoea, Hyperglycaemia, Lactic acidosis
Clinical narrative: Patient is a 68 y.o. male patient of local MD with a history of SOB   Discharge Diagnoses:   Assessment/Plan: Patient is a 68 y.o. male who presented to local Hospital 2/8/2023 with shortness of breath, weakness.   1. SIRS s/t PNA a. CT CAP without contrast: BLL consolidation/opacities c/w pneumonia 2. Lactic Acidosis a. 5.4 on admission, 3.0 (2/9) 3. Acute Hypoxemic Respiratory Failure (RESOLVED) 4. Bacterial Pneumonia BLL (CAP POA) a. Vanco stopped due to Cr level b. Rocephin continued Day #2.   5. Positive Blood Cx - S. Pneumoniae a. Blood PCR positive for S. Pneumoniae.  b. Was on Vanco and Zosyn, transitioned to IV Rocephin Day #2. Vanco stopped due to Cr.  6. COVID-19 Infection a. Date of onset of symptoms:  2/2/23 b. Symptoms present on admission: Hypoxemia c. Date of covid positive test:  2/8/23 d. Vaccination status:  x2 vaccines e. Imaging:   CT CAP with BLL pneumonia f. Oxygen requirements on admission:   3LPM g. Current oxygen requirements: RA h. Medical therapy: Decadron i. Consultants following:  Cardio, Nephrology consulted j. Anticipated special isolation end date 2/18/2023 k. CRP and Sed rate monitored--elevated 2/9 7. AKI on CKD a. Nephrology states okay to discharge. Recommends Lasix 40 mg daily  b. Likely multifactorial including COVID-19 creatinine has improved to 2.4 8. Hyperglycemia, Type II DM a. Elevation noted due to steroid use.  b. Will increase NPH dosing as current BG running 250-300s. 9. HF with mild reduction in EF, chronic a. Reviewed echo from 5/2022: EF 43%, grade II diastolic dysfunction, moderate LVH, moderate enlargement of the LA chamber, mild MV regurg, mild TV regurg, pulm HTN RVSP 43mmHg b. Continue antiarrhythmics and Eliquis per home regimen 10. Other Chronic Conditions include: CAD, HTN, H/O MI, H/O stent to LAD, H/O AFIB s/p ablation x1.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Lung consolidation, Lung opacity, Pneumonia, Pneumonia bacterial, Red blood cell sedimentation rate increased
Clinical narrative: Patient is a 68 y.o. male patient of local MD with a history of SOB   Discharge Diagnoses:   Assessment/Plan: Patient is a 68 y.o. male who presented to local Hospital 2/8/2023 with shortness of breath, weakness.   1. SIRS s/t PNA a. CT CAP without contrast: BLL consolidation/opacities c/w pneumonia 2. Lactic Acidosis a. 5.4 on admission, 3.0 (2/9) 3. Acute Hypoxemic Respiratory Failure (RESOLVED) 4. Bacterial Pneumonia BLL (CAP POA) a. Vanco stopped due to Cr level b. Rocephin continued Day #2.   5. Positive Blood Cx - S. Pneumoniae a. Blood PCR positive for S. Pneumoniae.  b. Was on Vanco and Zosyn, transitioned to IV Rocephin Day #2. Vanco stopped due to Cr.  6. COVID-19 Infection a. Date of onset of symptoms:  2/2/23 b. Symptoms present on admission: Hypoxemia c. Date of covid positive test:  2/8/23 d. Vaccination status:  x2 vaccines e. Imaging:   CT CAP with BLL pneumonia f. Oxygen requirements on admission:   3LPM g. Current oxygen requirements: RA h. Medical therapy: Decadron i. Consultants following:  Cardio, Nephrology consulted j. Anticipated special isolation end date 2/18/2023 k. CRP and Sed rate monitored--elevated 2/9 7. AKI on CKD a. Nephrology states okay to discharge. Recommends Lasix 40 mg daily  b. Likely multifactorial including COVID-19 creatinine has improved to 2.4 8. Hyperglycemia, Type II DM a. Elevation noted due to steroid use.  b. Will increase NPH dosing as current BG running 250-300s. 9. HF with mild reduction in EF, chronic a. Reviewed echo from 5/2022: EF 43%, grade II diastolic dysfunction, moderate LVH, moderate enlargement of the LA chamber, mild MV regurg, mild TV regurg, pulm HTN RVSP 43mmHg b. Continue antiarrhythmics and Eliquis per home regimen 10. Other Chronic Conditions include: CAD, HTN, H/O MI, H/O stent to LAD, H/O AFIB s/p ablation x1.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Streptococcus test positive, Systemic inflammatory response syndrome
Clinical narrative: Patient is a 68 y.o. male patient of local MD with a history of SOB   Discharge Diagnoses:   Assessment/Plan: Patient is a 68 y.o. male who presented to local Hospital 2/8/2023 with shortness of breath, weakness.   1. SIRS s/t PNA a. CT CAP without contrast: BLL consolidation/opacities c/w pneumonia 2. Lactic Acidosis a. 5.4 on admission, 3.0 (2/9) 3. Acute Hypoxemic Respiratory Failure (RESOLVED) 4. Bacterial Pneumonia BLL (CAP POA) a. Vanco stopped due to Cr level b. Rocephin continued Day #2.   5. Positive Blood Cx - S. Pneumoniae a. Blood PCR positive for S. Pneumoniae.  b. Was on Vanco and Zosyn, transitioned to IV Rocephin Day #2. Vanco stopped due to Cr.  6. COVID-19 Infection a. Date of onset of symptoms:  2/2/23 b. Symptoms present on admission: Hypoxemia c. Date of covid positive test:  2/8/23 d. Vaccination status:  x2 vaccines e. Imaging:   CT CAP with BLL pneumonia f. Oxygen requirements on admission:   3LPM g. Current oxygen requirements: RA h. Medical therapy: Decadron i. Consultants following:  Cardio, Nephrology consulted j. Anticipated special isolation end date 2/18/2023 k. CRP and Sed rate monitored--elevated 2/9 7. AKI on CKD a. Nephrology states okay to discharge. Recommends Lasix 40 mg daily  b. Likely multifactorial including COVID-19 creatinine has improved to 2.4 8. Hyperglycemia, Type II DM a. Elevation noted due to steroid use.  b. Will increase NPH dosing as current BG running 250-300s. 9. HF with mild reduction in EF, chronic a. Reviewed echo from 5/2022: EF 43%, grade II diastolic dysfunction, moderate LVH, moderate enlargement of the LA chamber, mild MV regurg, mild TV regurg, pulm HTN RVSP 43mmHg b. Continue antiarrhythmics and Eliquis per home regimen 10. Other Chronic Conditions include: CAD, HTN, H/O MI, H/O stent to LAD, H/O AFIB s/p ablation x1.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Cough, Dizziness, Dyspnoea, Fatigue
Clinical narrative: Hospitalized 7/24/22-7/27/22 rectal bleed, dyspnea, fatigue, cough, dizziness, anemia,
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Rectal haemorrhage
Clinical narrative: Hospitalized 7/24/22-7/27/22 rectal bleed, dyspnea, fatigue, cough, dizziness, anemia,
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cough, Dyspnoea
Clinical narrative: Patient with history of asthma, seizures, and HIV. He was brought to the ED by EMS on 12/9/22 for cough for the past 10 days, along with shortness of breath, fatigue and malaise for the past 2 days. EMS noted his O2 sats were at 88% so was placed on 2L O2 NC. He tested positive for COVID by PCR that same day. He was admitted 12/9/22 - 12/15/22 for further management of COVID-19 and superimposed bacterial pneumonia. Discharge diagnoses include acute hypoxic respiratory failure, COVID-19 pneumonia with superimposed bacterial pneumonia, severe sepsis at presentation due to bacterial pneumonia, COVID-19 infection, among other diagnoses.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Fatigue, Malaise, Oxygen saturation decreased, Pneumonia bacterial, SARS-CoV-2 test positive
Clinical narrative: Patient with history of asthma, seizures, and HIV. He was brought to the ED by EMS on 12/9/22 for cough for the past 10 days, along with shortness of breath, fatigue and malaise for the past 2 days. EMS noted his O2 sats were at 88% so was placed on 2L O2 NC. He tested positive for COVID by PCR that same day. He was admitted 12/9/22 - 12/15/22 for further management of COVID-19 and superimposed bacterial pneumonia. Discharge diagnoses include acute hypoxic respiratory failure, COVID-19 pneumonia with superimposed bacterial pneumonia, severe sepsis at presentation due to bacterial pneumonia, COVID-19 infection, among other diagnoses.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Sepsis, Superinfection
Clinical narrative: Patient with history of asthma, seizures, and HIV. He was brought to the ED by EMS on 12/9/22 for cough for the past 10 days, along with shortness of breath, fatigue and malaise for the past 2 days. EMS noted his O2 sats were at 88% so was placed on 2L O2 NC. He tested positive for COVID by PCR that same day. He was admitted 12/9/22 - 12/15/22 for further management of COVID-19 and superimposed bacterial pneumonia. Discharge diagnoses include acute hypoxic respiratory failure, COVID-19 pneumonia with superimposed bacterial pneumonia, severe sepsis at presentation due to bacterial pneumonia, COVID-19 infection, among other diagnoses.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Deep vein thrombosis, Exposure during pregnancy, Gait disturbance, Muscle spasms
Clinical narrative: I HAD THE 2ND MODERNA VACCINE ON 2-5-21. AT THIS TIME I WAS 6WK PREGNANT, MY ESTIMATED DUE DATE IS 9-28-21, AND I HAVE HAD ONE PREVIOUS UNEVENTFUL PREGNANCY. ON 2-8-21 I FELT A CRAMPING SENSATION IN MY LEFT CALF, WHICH INTENSIFIED THROUGH THE DAY. I WENT TO THE URGENT CARE, WHO SENT ME TO VASCULAR TO HAVE A DUPLEX ON MY LEG, WHICH WAS NEGATIVE. THROUGH THE WEEK THE CRAMPING INTENSIFIED EVEN MORE, AND MY LEG BECAME PAINFUL AND SWOLLEN TO THE POINT WHERE I COULD NEARLY WALK. I RETURNED TO VASCULAR, WHO DID ANOTHER SCAN ON MY LEG WHICH SHOWED NOT ONE, BUT 2 SEPARATE DVT'S.  I AM NOW ON LOVENOX TWICE DAILY THROUGH 6 WEEKS POST PARTUM.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Ultrasound Doppler abnormal
Clinical narrative: I HAD THE 2ND MODERNA VACCINE ON 2-5-21. AT THIS TIME I WAS 6WK PREGNANT, MY ESTIMATED DUE DATE IS 9-28-21, AND I HAVE HAD ONE PREVIOUS UNEVENTFUL PREGNANCY. ON 2-8-21 I FELT A CRAMPING SENSATION IN MY LEFT CALF, WHICH INTENSIFIED THROUGH THE DAY. I WENT TO THE URGENT CARE, WHO SENT ME TO VASCULAR TO HAVE A DUPLEX ON MY LEG, WHICH WAS NEGATIVE. THROUGH THE WEEK THE CRAMPING INTENSIFIED EVEN MORE, AND MY LEG BECAME PAINFUL AND SWOLLEN TO THE POINT WHERE I COULD NEARLY WALK. I RETURNED TO VASCULAR, WHO DID ANOTHER SCAN ON MY LEG WHICH SHOWED NOT ONE, BUT 2 SEPARATE DVT'S.  I AM NOW ON LOVENOX TWICE DAILY THROUGH 6 WEEKS POST PARTUM.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Injection site pain, Musculoskeletal stiffness, Neck pain
Clinical narrative: 4/2 ~4/3: No daily exercised (30 pushups in the morning) during these two days. 4/4/2021: Resumed daily exercise, and walked a few miles (usually 2-3 times weekly)? leg and butt pain April 5-7: stiff neck symptoms: back, right arm, shoulder, and neck pain,  April 8-11: stiff neck kind of symptoms: back, left shoulder, and neck pain April 10-11: stiff neck kind of symptoms (back, left shoulder, and neck pain) + injection site pain (left arm) April 11-13: continued left arm injection site pain. April 14: waked up with less left arm injection site pain. After daily pushups, continued left arm injection site pain. April 15:  waked up with less left arm injection site pain,
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: 4/2 ~4/3: No daily exercised (30 pushups in the morning) during these two days. 4/4/2021: Resumed daily exercise, and walked a few miles (usually 2-3 times weekly)? leg and butt pain April 5-7: stiff neck symptoms: back, right arm, shoulder, and neck pain,  April 8-11: stiff neck kind of symptoms: back, left shoulder, and neck pain April 10-11: stiff neck kind of symptoms (back, left shoulder, and neck pain) + injection site pain (left arm) April 11-13: continued left arm injection site pain. April 14: waked up with less left arm injection site pain. After daily pushups, continued left arm injection site pain. April 15:  waked up with less left arm injection site pain,
Age: 0.75
Sex: M
Vaccine: COVID19
Symptoms: Ear infection, Infant irritability, Otorrhoea, Rhinorrhoea, Tympanic membrane perforation
Clinical narrative: He had a snotty nose and I saw some goop in his ear. I wiped it and he got very upset when I cleaned it. This happened again in about an hour, but it was a lot more goop. I took him to the emergency room, and he diagnosed a ruptured ear drum on the right side and a mild ear infection the left. They prescribed amoxicillin and we stated it that day. We had a follow up with his primary care and he said it was healing up great. He is completely healed now.
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event, Product packaging confusion
Clinical narrative: no adverse effects. patient received a bivalent 0.2ml dose instead of a monovalent 0.2ml dose. The vials look almost identical - both orange, both same size, both same dilution, and both same dose. Pharmacist did not notice the labeling difference. Correct age vaccine administered, but bivalent instead of monovalent.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: GIVEN PAST BUD
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Wound
Clinical narrative: open wound on underside of arm approx 5-6 hours after vaccination.  Evaluated by telehealth visit with PCP- started on an antibiotic
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, SARS-CoV-2 test positive
Clinical narrative: It started later in the day, in the afternoon, I felt extremely fatigued and a scratchy throat. It proceeded into a headache during that night. I may had had a dry cough, but it wasn't horrible. It wasn't constant either. I did not think too much of the extreme fatigue at first but how it hit me, I felt something really wrong. By the next day it lingered and by Sunday, I tested a home test and tested positive. I called my doctor and was told to go to a drive-in test center and was tested there and came positive. I was given PAXLOVID. I feel normal now.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: It started later in the day, in the afternoon, I felt extremely fatigued and a scratchy throat. It proceeded into a headache during that night. I may had had a dry cough, but it wasn't horrible. It wasn't constant either. I did not think too much of the extreme fatigue at first but how it hit me, I felt something really wrong. By the next day it lingered and by Sunday, I tested a home test and tested positive. I called my doctor and was told to go to a drive-in test center and was tested there and came positive. I was given PAXLOVID. I feel normal now.
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: GIVEN AFTER BUD
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, Dyspnoea, Head injury
Clinical narrative: Patient with history of asthma, diabetes. Patient brought to the ED by EMS on 12/9/22 after sustaining a head injury - she rolled out of bed and hit her head. Additionally, she reported shortness of breath, noting that for the past week she has been feeling generalized weakness, body aches, subjective fever, and congestion. A COVID PCR test was done which resulted positive. Ultimately patient admitted 12/9/22 - 12/18/22. Discharge diagnoses include acute hypoxic and hypercarbic respiratory failure, COVID-19, among other diagnoses. During admission, patient used BiPAP as needed for excessive work of breathing and overnight. Patient has received the COVID primary vaccine series.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Positive airway pressure therapy, Pyrexia, Respiratory failure, Respiratory tract congestion
Clinical narrative: Patient with history of asthma, diabetes. Patient brought to the ED by EMS on 12/9/22 after sustaining a head injury - she rolled out of bed and hit her head. Additionally, she reported shortness of breath, noting that for the past week she has been feeling generalized weakness, body aches, subjective fever, and congestion. A COVID PCR test was done which resulted positive. Ultimately patient admitted 12/9/22 - 12/18/22. Discharge diagnoses include acute hypoxic and hypercarbic respiratory failure, COVID-19, among other diagnoses. During admission, patient used BiPAP as needed for excessive work of breathing and overnight. Patient has received the COVID primary vaccine series.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient with history of asthma, diabetes. Patient brought to the ED by EMS on 12/9/22 after sustaining a head injury - she rolled out of bed and hit her head. Additionally, she reported shortness of breath, noting that for the past week she has been feeling generalized weakness, body aches, subjective fever, and congestion. A COVID PCR test was done which resulted positive. Ultimately patient admitted 12/9/22 - 12/18/22. Discharge diagnoses include acute hypoxic and hypercarbic respiratory failure, COVID-19, among other diagnoses. During admission, patient used BiPAP as needed for excessive work of breathing and overnight. Patient has received the COVID primary vaccine series.
Age: 23.0
Sex: M
Vaccine: HEP
Symptoms: Chills, Dyspnoea, Hot flush, Hyperhidrosis, Injection site pain
Clinical narrative: Employee description of symptoms are as follows :Chills , hot flashes sweating,  runny nose, pain at injection site and shortness of breath. time of  symptoms is as follow 03/01/2023  8:00AM.  Employee states" no use of OTC medication  just went to sleep "
Age: 23.0
Sex: M
Vaccine: HEP
Symptoms: Rhinorrhoea
Clinical narrative: Employee description of symptoms are as follows :Chills , hot flashes sweating,  runny nose, pain at injection site and shortness of breath. time of  symptoms is as follow 03/01/2023  8:00AM.  Employee states" no use of OTC medication  just went to sleep "
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product use issue
Clinical narrative: GIVEN PAST BUD
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Carotid artery stenosis, Cerebrovascular accident, Confusional state, Dysuria
Clinical narrative: Hospitalized 8/1/22-8/8/22 confusion, nausea, bilateral flank pain, hemiplegia, weakness, numbness, UTI, dysuria,  CVA, carotid stenosis,
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flank pain, Hemiplegia, Hypoaesthesia, Nausea, Urinary tract infection
Clinical narrative: Hospitalized 8/1/22-8/8/22 confusion, nausea, bilateral flank pain, hemiplegia, weakness, numbness, UTI, dysuria,  CVA, carotid stenosis,
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Cerebrovascular accident, Facial paralysis, Monoplegia
Clinical narrative: Stroke with right side hand and mouth paralysis. Patient was treated with plavix for 30 days
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 02/15/23 presents to ED for "shortness of breath". PMHx of "CAD s/p CABG, atrial fibrillation on AC, SSS s/p PPM, HTN, HLD"
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: 3RD DOSE OF MODERNA COVID VACCINE GIVEN 11/23/21, #939909. pt had a positive COVID test on 8/17/22 from Urgent Care; 9/15/22 pt's passing was witnessed at home by family; brought to ED to be pronounced; pronounced deceased at Medical Center.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 02/15/23 presents to ED for "SOB". PMHx of " arthritis, basal cell carcinoma, hypertension, stroke, history of cardiac catheterization, PFO"
Sex: M
Vaccine: UNK, UNK
Symptoms: Extra dose administered
Clinical narrative: patient received extra dose of IPV  received Pentacel  and IPV on same day
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Cough, Hyponatraemia, Nausea, Vomiting
Clinical narrative: Observation 7/27/22-7/28/22 nausea, vomiting, cough, confusion, hyponatremia,
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, COVID-19, Death, General physical health deterioration, Pain
Clinical narrative: 8/23/22 pt had a positive COVID test at Center; was give Azithromycin and Medrol Pak; 8/27/22 pt brought to ED with fever, body aches, O2 saturation in 80s; O2 supplementation; CTA chest shows multifocal pneumonia; pt's condition worsened; transitioned to DNR, comfort measures; family requested BiPAP to be removed and patient passed away in the hospital
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia, Positive airway pressure therapy, Pyrexia, SARS-CoV-2 test positive, Therapy cessation
Clinical narrative: 8/23/22 pt had a positive COVID test at Center; was give Azithromycin and Medrol Pak; 8/27/22 pt brought to ED with fever, body aches, O2 saturation in 80s; O2 supplementation; CTA chest shows multifocal pneumonia; pt's condition worsened; transitioned to DNR, comfort measures; family requested BiPAP to be removed and patient passed away in the hospital
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Dyspnoea, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 02/16/23 presents to ED for "fatigue, shortness of breath and chest pain". PMHx of ", HLD, heart murmur, atrial flutter"
Age: 1.58
Sex: F
Vaccine: MMRV
Symptoms: Product preparation issue
Clinical narrative: Reconstituted vaccine with provided 0.7mL diluent and total volume of vaccine was 0.72mL 0.5mL was administered per manufacturer website and package dosing  Vaccine insert states to give the total amount despite a 0.5mL dose Unsure if this constitutes a valid administration due to conflicting information with vaccine insert and instructions Was asked to make a report based on conflicting and unclear administration details
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site reaction, Injection site swelling
Clinical narrative: Patient had slightly larger than a localized reaction on his upper right arm- very red, firm, swollen
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Aspiration, Cough, Dyspnoea, Endotracheal intubation
Clinical narrative: Hospitalized 7/29/22-8/2/22 cough, fever, aspiration at intubation 7/27/22, SOB, body aches, tachypnea, PNA, hypoxia, anemia,
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Pain, Pneumonia, Pyrexia, Tachypnoea
Clinical narrative: Hospitalized 7/29/22-8/2/22 cough, fever, aspiration at intubation 7/27/22, SOB, body aches, tachypnea, PNA, hypoxia, anemia,
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Injection site pain, Wrong technique in product usage process
Clinical narrative: Patient complained of limited movement in left arm 24 hours after injection.  She stated that she thinks the injector either "hit a tendon" or placed the injection off to the side of the deltoid.  She also stated that that evening after injection she used both arms to carry buckets.  This type of activity was not of the ordinary for her.   As of 3/2023 she feels as if she can still locatethe site of injection due to tenderness.
Age: 0.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered
Clinical narrative: Administered expired vaccine
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: 2/6 very mild symptoms fatigue, achy, congested. Tested positive on an at home COVID-19 test, positive. Televisit with doctor. Prescribed PAXLOVID. Aches and congestions gone by day 5, fatigue lingered until day 7.
Sex: M
Vaccine: UNK, UNK, UNK, UNK
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Infant in clinic for first health check. Patient healthy and growth chart shows gaining weight, gaining length. During the health check, I inadvertantly administered required 2 month vaccines to a 22 day old infant. I did not utilize the recommended immunzation schedule for children and adolescent guide before administering the immunizations listed above. Upon my mistake, I contacted the parents reporting the error and to check on the health of the infant. Mother reports no adverse reaction at the time of phone call. Advised to call with questions or concerns.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Dyspnoea, Oropharyngeal pain, Pyrexia, Respiratory tract congestion
Clinical narrative: Symptoms felt like I had a really bad sinus infection. I came back from a business trip and felt congested, with a sore throat, hard time breathing and low grade fever. I got home Saturday night and decided to test. I was also testing every day during my trip. I tested positive with two different at home COVID-19 kits. That was 01/08/2023. On 01/09/2023 I contacted my physician and did a televisit with him. He put me on PAXLOVID and I started that that evening. I did continue to test until I was negative. First negative test was on 01/22/2023.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sinusitis
Clinical narrative: Symptoms felt like I had a really bad sinus infection. I came back from a business trip and felt congested, with a sore throat, hard time breathing and low grade fever. I got home Saturday night and decided to test. I was also testing every day during my trip. I tested positive with two different at home COVID-19 kits. That was 01/08/2023. On 01/09/2023 I contacted my physician and did a televisit with him. He put me on PAXLOVID and I started that that evening. I did continue to test until I was negative. First negative test was on 01/22/2023.